SCHEMBL312286

SCHEMBL312286

CCOC(=O)Nc1cc(O)ccc1-c1nc(=O)c2cccc(O)c2o1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.44
HPGD P15428 4/20 0.44
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 4/20 0.42
HSD17B10 Q99714 2/20 0.42
LMNA P02545 1/20 0.42
GLA P06280 1/20 0.41
POLB P06746 1/20 0.41
MAOA P21397 3/20 0.40
AGPAT2 O15120 1/20 0.38
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
ELANE P08246 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311616 0.87 KDM4E (0.52) MAOBHPGDALDH1A1KDM4EHSD17B10
SCHEMBL313410 0.86 MAOB (0.48) MAOBHPGDALDH1A1KDM4EHSD17B10
SCHEMBL313237 0.84 MAOB (0.47) MAOBHPGDALDH1A1KDM4EHSD17B10
SCHEMBL312986 0.84 MAOB (0.47) MAOBHPGDALDH1A1KDM4EHSD17B10
SCHEMBL311431 0.82 HPGD (0.46) MAOBHPGDALDH1A1KDM4EHSD17B10
SCHEMBL311430 0.78 KDM4E (0.53) MAOBHPGDALDH1A1KDM4EHSD17B10
SCHEMBL313004 0.75 ATM (0.52) MAOBHPGDALDH1A1KDM4EHSD17B10
SCHEMBL312367 0.75 KDM4E (0.52) MAOBHPGDALDH1A1KDM4EHSD17B10
SCHEMBL324201 0.73 HPGD (0.61) MAOBHPGDALDH1A1KDM4EHSD17B10
SCHEMBL10215504 0.73 MAOB (0.52) MAOBHPGDALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838296-B1 FLAVANOIDS AND ISOFLAVANOIDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES RESVERLOGIX CORP (CA) 2012-08-08 EP disclosed
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed